November 15, 2024

Japan Prosecutors Raid Olympus and Former Executive’s Home

TOKYO (AP) — Japanese prosecutors raided the headquarters of Olympus Corp. and the home of its former president Wednesday as part of an investigation into the cover-up of massive losses at the camera and medical equipment maker.

A trail of dark-suited officials was shown on national television marching solemnly into the company’s downtown Tokyo office building.

Olympus said it would fully cooperate with the investigation by prosecutors, police and financial authorities.

“We apologize deeply again for the great troubles and worries we have caused our shareholders, investors, customers and others,” it said in a statement.

Tokyo prosecutors said the home of former President Tsuyoshi Kikukawa, who is suspected of helping to orchestrate the cover-up, was also raided, as were the offices of three companies used in the scheme.

The deception at Olympus dates back to the 1990s and involved an elaborate scheme to hide 117.7 billion yen ($1.5 billion) in investment losses. It only came to light in October when then President Michael Woodford blew the whistle on what he thought was strange and excessive spending.

Woodford, a Briton, had been a rare foreigner to head a major Japanese company.

The scandal has raised serious questions about corporate governance in Japan, and whether major companies are complying adequately with global standards.

Woodford was fired after he confronted the company’s board of directors with his doubts. In recent weeks, he has been trying to stage a comeback to the top, by appealing to shareholders, employees and others that his return will work to clean up Olympus.

Woodford had questioned exorbitant fees for advice on the acquisition of British medical equipment maker Gyrus Group and other expensive acquisitions in 2008.

Woodford is demanding the resignation of the entire board, including President Shuichi Takayama, who replaced him and initially declared in a news conference that the spending was legitimate.

The battle over who will lead the camera and medical equipment maker and its 40,000 employees could come to a head at the next shareholders’ meeting. A date has not been set.

The new Olympus management has expressed a willingness to consider alliances in an effort to get its finances back in order.

Olympus delayed reporting earnings because of the accounting irregularities, but met the stock exchange’s deadline earlier this month, averting automatic removal from the market.

The company could still be delisted if the criminal investigation discloses major misbehavior.

In the past, erring executives have rarely got prison time for their roles in shady bookkeeping.

Covering up for investments that went sour after the 1980s “bubble” economy burst was so widespread in Japan that a special term describes the practice, “tobashi.”

Olympus stock plunged amid the scandal but has recouped some of those losses in recent weeks. On Wednesday it slipped 1.4 percent to 1,050 yen.

___

Follow Yuri Kageyama on Twitter at http://twitter.com/yurikageyama

Article source: http://feeds.nytimes.com/click.phdo?i=9efa22efc7caa8844629711b4e24df9c

Olympus Chairman Resigns Amid Widening Scandal

Tsuyoshi Kikukawa had taken charge of Olympus on Oct. 14 after he abruptly fired the former head of the company, the Briton Michael C. Woodford, citing cultural differences in management styles.

But Mr. Woodford later said he had been fired after raising questions over a series of acquisitions made by Olympus at what he said were inexplicably high prices or involving disproportionately pricey advisory fees.

Mr. Woodford said exorbitant fees to the tune of $687 million
were paid to now defunct advisory companies for Olympus’s 2008 acquisition of Gyrus, a British medical equipment maker.

Other deals
have also come under scrutiny. Documents show that Nobumasa Yokoo, who runs a consulting firm that Olympus hired to advise it on acquisitions, directed hundreds of millions of Olympus’s dollars into buying three unprofitable start-up companies — with which he himself had been involved as an investor or executive — only to have Olympus quickly write off most of their value.

In the turmoil since Mr. Woodford’s departure, Olympus shares have lost over half their value. The shares dropped a further 7.6 percent in Tokyo on Wednesday, closing at ¥1,099, or $14.48.

Some of its largest shareholders have demanded more disclosure over the acquisitions, including who the payments were made out to and whether there were any conflicts of interest in any of the dealings.

The Federal Bureau of Investigation has also started to look into the payments related to the Gyrus deal. Olympus has promised a third-party investigation into the matter.

Shuichi Takayama, a managing director of the company, will replace Mr. Kikukawa as president, Olympus said. Mr. Kikukawa will become a director without representative rights, effective immediately, the company said.

“Recognizing the seriousness of the situation, I have decided to spearhead our efforts to restore confidence” in the company, Mr. Takayama told a press conference in Tokyo, after giving the customary deep bow reserved for public apologies over grave missteps. Mr. Takayama, 61, a 40-year veteran of the company, most recently led Olympus’s imaging business.

He directed his apologies, however, toward the “inconvenience and concern” the recent turmoil had caused to Olympus shareholders. He said he could not discuss the two deals questioned by Mr. Woodford because the company intended to wait for the findings of the third-party investigation. Olympus has not yet said who will lead the investigation.

Mr, Takayama denied the possibility of any company ties to organized crime, suggested by some tabloids in Japan. “I am not aware of that at all,” he said. He also denied that Mr. Kikukawa, known to be a powerful presence on the Olympus board, would continue to wield his influence. Mr. Takayama said that he would act based on his own thinking.

Mr. Woodford has likened the Olympus board to an “Emperor system” run by Mr. Kikukawa. Mr. Kikukawa was not present at the news conference Wednesday.

Mr. Woodford, in New York to meet with F.B.I. officials, said that Mr. Kikukawa’s resignation was not enough to win back investor confidence in Olympus. The Briton had demanded that the entire board — who had been aware of his allegations, he said, yet voted to fire him instead of investigating the claims — should go.

“They haven’t answered any of the questions” over the acquisitions, Mr. Woodford said by telephone. Without a more sweeping change at the top of the company, the management “will continue to take the company to the rocks,” he said.

“They need someone who has not been contaminated by this issue,” he said. “They need someone who will then be able to explain, in substantive and definitive terms, what this has been all about.”

Article source: http://www.nytimes.com/2011/10/27/business/global/olympus-chairman-resigns-amid-widening-scandal.html?partner=rss&emc=rss

Acquisitions at Olympus Scrutinized

TOKYO — Even as the F.B.I. in the United States investigates exorbitant advisory fees that the Japanese company Olympus paid to a firm with links to the Cayman Islands, a second set of deals is drawing scrutiny here in Japan.

These other deals, which caused Olympus to lose hundreds of millions of dollars, involved an enterprising ex-Nomura banker and his well-connected older brother, whose roles have not yet received much public attention.

The former banker, Nobumasa Yokoo, runs a consulting firm that Olympus hired to advise it on acquisitions. Among other deals, documents show, Mr. Yokoo directed hundreds of millions of Olympus’s dollars into buying three money-losing start-up companies — with which he himself had been involved as an investor or executive — only to have Olympus quickly write off most of their value.

His older brother, Akinobu Yokoo, headed an investment unit that steered Olympus’s money into various other companies — from e-commerce to Italian restaurants — that had little to do with the business of making medical imaging equipment and digital cameras. A write-down of those investments helped plunge Olympus into the red in the fiscal year that ended in March 2009.

It is unclear how the Yokoo brothers became so involved in Olympus’s acquisition strategy. But their roles are evident from an examination of publicly available company filings and reports by credit ratings companies, as well as financial documents provided by Olympus’s recently ousted chief executive, Michael Woodford.

Mr. Woodford contends that he was fired after confronting the company’s chairman and board over the three deals linked to the younger Yokoo brother as well as exorbitant fees paid over Olympus’s 2008 acquisition of the British medical equipment maker Gyrus after the Japanese financial magazine Facta raised questions about the purchases. In the turmoil since Mr. Woodford’s firing on Oct. 14, Olympus shares have lost almost half their value. The transactions involving the Yokoos are separate from the Gyrus acquisition, which is currently the subject of an investigation in the United States by the Federal Bureau of Investigation. Mr. Woodford on Monday night said he was in contact with the F.B.I., though he declined to elaborate.

Documents most clearly link the younger Yokoo brother with at least three of the companies he later advised Olympus to acquire between 2006 and 2008 for a total of $773 million. Those companies — Humalabo, a maker of face creams; News Chef, a manufacturer of microwavable cookware; and Altis, a medical waste recycler — were relatively new and had never made money, credit research reports show. Olympus wrote off three-quarters of that total investment within a year of completing the deals.

Olympus says it has done nothing wrong other than making some business bets that turned sour. Nobumasa Yokoo could not be located for questions, while Akinobu Yokoo’s current employer would not make him available for comment.

So far, Japanese authorities have not indicated they are investigating the deals involving Nobumasa Yokoo, and neither brother has been accused of any wrongdoing.

But investors are pressing Olympus for answers. In an Oct. 20 letter, Southeastern Asset Management, an American money manager, with a 5 percent stake, demanded full disclosure on the three acquisitions — including whether any parties related to Olympus were affiliated with their previous owners.

“The questions that have been raised cannot go unanswered,” Southeastern Asset Management wrote. Olympus said last week it would form an independent panel to investigate the acquisitions, in light of shareholder pressure.

Nobumasa Yokoo’s part of the story traces as far back as 1998, to his days at the Japanese financial powerhouse Nomura. According to company records at the time, Mr. Yokoo — who had also spent time on Wall Street at Wasserstein Perella — was head of Nomura’s prestigious Shinjuku Nomura Building branch. There, he dealt with some of the firm’s top clients, including Olympus.

But in June of that year, he and many others at the firm chose to leave after a scandal involving payoffs to Japan’s organized crime gangs led to resignations, and later arrests, of top executives. Mr. Yokoo was not implicated in the scandal. But he left, telling the Nikkei business daily at the time that he wished “to be able to cook the rice I live on.”

Shortly afterward, Mr. Yokoo founded Global Company, a management consulting firm, according to Global’s legal filings.

Article source: http://www.nytimes.com/2011/10/25/business/global/acquisitions-at-olympus-scrutinized.html?partner=rss&emc=rss

Murdoch Vows to Remain C.E.O as News Corporation’s Profit Falls

Opinion »

Fixes: Making Medical Donations Work

Shipping unused medical equipment to poor hospitals is a great idea, but it has to be done right.

Article source: http://feeds.nytimes.com/click.phdo?i=4f46c6eff50ed130ac4072223d0b0c2f

China Trade Surplus Rises Sharply

Opinion »

Fixes: Making Medical Donations Work

Shipping unused medical equipment to poor hospitals is a great idea, but it has to be done right.

Article source: http://feeds.nytimes.com/click.phdo?i=e336fc00b99f65b3ed8b7d54d05c5c52